Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.

By R. Bellomo, M. Chapman, S. Finfer, K. Hickling, J. Myburgh. 2000

932 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/b9840e8563bc4503b28c096d4caf2c45b529c931

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

In Nephrology

Citations in the corpus

Pathophysiology of Acute Kidney Injury (2012, neutral): “Despite this, multiple studies have consistently demonstrated that renal-dose dopamine or the dopamine agonist fenoldapam, do not influence outcome of AKI in patients despite producing diuresis (45, 254, 255, 288, 560).”
Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. (2009, background): “Despite significant advances in our nderstanding of the pathophysiologic characterstics of AKI, several interventions for AKI have een proved ineffective.(4-6) This failure is caused n part by the lack of real-time sensitive and pecific renal biomarkers to allow the early diag-”
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis (2010, neutral): “In 2002, hopeful that outcomes of sepsis might be improved by standardizing care and informed by data from an increasing number of clinical trials [3–10], the European Society of Intensive Care Medicine (ESICM), the International Sepsis Forum (ISF), and the Society of Critical Care Medicine (SCCM)…”
Acute kidney injury (2012, background): “[80]”
Critical care - where have we been and where are we going? (2013, background): “For example, blood transfusion triggers could be reduced to lower levels than the widely used 10 g/dl cutoff value [18]; high tidal volumes were shown to be detrimental [19]; the administration of low-dose dopamine to prevent renal failure was shown to be of no benefi t [20]; routine insertion of th”
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (2004, background): “Thus, the available data do not support administration of low doses of dopamine to maintain or improve renal function (31, 32).”
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 (2013, background): “A large randomized trial and meta-analysis comparing low-dose dopamine to placebo found no difference in either primary outcomes (peak serum creatinine, need for renal replacement, urine output, time to recovery of normal renal function) or secondary outcomes (survival to either ICU or hospital disc”